Market Forecasting

Make Confident Commercial Decisions with Robust, Indication-Level Forecasts

Accurate market forecasting is essential for strategic planning, commercialization, and investment decisions in the biopharma industry. Thelansis delivers evidence-driven forecasting models that integrate epidemiology, patient flow, competitive intelligence, pricing, reimbursement, and market dynamics to generate realistic commercial projections. Our transparent, data-driven approach supports opportunity assessments, launch planning, licensing, portfolio optimization, lifecycle management, and long-term business growth.

Data-Driven Forecasting

Market Opportunity Evaluation

Strategic Commercial Planning

Why Market Forecasting Matters

In today’s competitive pharmaceutical landscape, forecasting is no longer just a financial exercise; it is a strategic capability that informs virtually every major business decision.

Without robust forecasting methodologies, organizations risk:

Overestimating commercial potential
Misallocating development resources
Underestimating competitive threats
Delaying market entry decisions
Inefficient manufacturing capacity planning
Poor valuation of pipeline assets
Missed investment opportunities

By integrating epidemiology, market dynamics, and competitive intelligence into forecasting models, organizations can better understand uncertainty, evaluate scenarios, and make evidence-based strategic decisions.

Market forecasting also provides a common planning framework across commercial, finance, R&D, business development, and executive leadership teams, ensuring alignment around realistic expectations and growth opportunities.

What We Do

Thelansis provides comprehensive forecasting services that support strategic planning across the product lifecycle. Our capabilities include:

Epidemiology-Based Market Sizing

Patient Flow Modeling

Revenue Forecast Development

Competitive Landscape Forecasting

Portfolio and Asset Valuation

Executive Decision Support

Our Market Forecasting Methodology

At Thelansis, our forecasting methodology combines scientific expertise with commercial intelligence to produce transparent, defensible, and actionable projections. Rather than relying solely on historical sales analogs, we build bottom-up models that reflect the unique characteristics of each indication, therapy, and market.

Epidemiology and Patient Population Modeling
Patient Journey and Treatment Flow Analysis
Competitive Intelligence Integration
Pricing and Market Access Assessment
Revenue and Uptake Modeling
Scenario Planning and Sensitivity Analysis

We Provide Answers to Critical Questions

Our forecasting analyses help organizations answer essential commercial and strategic questions such as:

What is the true commercial potential of our asset?

How will competitor entries reshape adoption curves and market share?

Which countries should be prioritized for launch?

How sensitive are revenues to pricing or reimbursement changes?

Which assumptions introduce the greatest financial risk?

Which scenarios justify further investment or partnership?

Key Deliverables

Clients receive customized forecasting outputs designed to support executive decision-making and commercial planning. Typical deliverables include:

Market sizing reports

Patient flow models

Revenue forecasts

Country-level forecasts

Competitive impact analyses

Scenario planning reports

Sensitivity analyses

Launch sequencing recommendations

Portfolio valuation support

Executive dashboards

Benefits of Partnering with Thelansis

Organizations partnering with Thelansis gain access to forecasting expertise that combines scientific rigor with commercial realism. Our clients benefit from: